News
-
-
-
PRESS RELEASE
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re plans dividend of €20 per share for 2024 and resolves share buy-back with volume of up to €2.0bn
Munich Re plans €20 dividend per share for 2024 and approves €2.0bn share buy-back program. Inside information disclosed by the Board of Management -
PRESS RELEASE
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering
Wellgistics Health, Inc. concludes IPO of 888,889 shares at $4.50 each on Nasdaq Capital Market with expected $4.0 million proceeds for healthcare and pharmaceutical services expansion -
-
-
-
-
PRESS RELEASE
EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: Appointment of Dr. Michael Mertin as new Chief Executive Officer (CEO) of AT&S AG
AT&S AG appoints Dr. Michael Mertin as new CEO, effective May 1, 2025, for a 3-year term. Dr. Mertin joins Management Board. AT&S focuses on IC substrates, PCBs, and interconnect technologies globally -
